NCT07723534

Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-08Est. Completion: 2029-02

Enrollment target: 32 participants

Locations

Contact

Cancer Harboring BRAF AlterationsHGGLGGSolid Tumors

The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF a…

Beverly Hills, United StatesEst. completion Dec 31, 2027

Advanced Biliary Tract Cancers

This is a prospective, single-arm, Phase II study evaluating sacituzumab tirumotecan combined with envafolimab in patien…

Tianjin, ChinaEst. completion Dec 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.